Logan Lutton

Pennsylvania-based UPMC has reached a definitive agreement with CommonSpirit Health to acquire Trinity Health System, expanding its footprint into eastern Ohio.

A pilot study of demodex mites and antimicrobial peptides published in the Journal of the American Academy of Dermatology found biologic differences between sensitive skin syndrome and rosacea, suggesting the conditions are distinct despite sharing similar symptoms and triggers.

A French study found that a higher dose of ivermectin was not more effective than the standard dose when combined with topical therapy for treating severe scabies.

Young adults with HIV who experience financial instability are significantly more likely to struggle with adhering to antiretroviral therapy, highlighting how economic hardship can directly impact treatment success.

New research suggests that both insufficient and excessive sleep may be linked to faster aging throughout the body and an increased risk of conditions such as depression, diabetes and heart disease.

Affordable Care Act Marketplace deductibles hit a record 37% increase in 2026 as expired enhanced tax credits pushed millions of enrollees toward cheaper, higher-deductible bronze plans.

Ferdinandos Skoulidis, M.D., Ph.D., explains what’s next for this treatment for patients with previously untreated advanced or metastatic KRAS G12C-mutated non-small cell lung cancer.

A new investigational combination therapy for advanced KRAS G12C-mutant non-small cell lung cancer showed "highly promising" results with “manageable” side effects, according to the study’s lead author.

Divarasib plus pembrolizumab shows strong responses in patients with advanced KRAS G12C+ non-small cell lung cancer, according to the results of the Krascendo 170 study, presented today at ASCO 2026.

A phase 3 clinical trial presented at ASCO 2026 found that combining talazoparib with enzalutamide reduced the risk of cancer progression by 52% compared with enzalutamide alone in prostate cancer patients with specific DNA repair gene mutations, with even greater benefit seen in those carrying BRCA mutations.